Protara TherapeuticTARA
13F holders, Q1 2024 (March 31)34holders
2famous investors
$4.01avg. 13F price*
At the end of Q1 2024, 34 institutions reported holding Protara Therapeutic Inc. (TARA) in their 13F filings. The largest holders were Opaleye Management Inc. ($10.8M), Vanguard Group Inc. ($1.7M) and Boxer Capital, LLC ($839K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Protara Therapeutic Inc.
- CUSIP
- 74365U107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.0M |
| Exits | 3 | $51K |
Ownership 34 holders
| Opaleye Management Inc. | 2.37% | No change | 2,692,594 | $10.8M |
| Vanguard Group Inc. | 0.00% | No change | 427,612 | $1.7M |
| Boxer Capital, LLC | 0.04% | No change | 209,227 | $839K |
| Ikarian Capital, LLC | 0.22% | Add +7.4% | 202,701 | $813K |
| Baker Bros. Advisors LP | 0.01% | No change | 199,671 | $801K |
| Stempoint Capital LP | 0.18% | New | 168,442 | $675K |
| Privium Fund Management (UK) Ltd | 0.25% | No change | 119,730 | $496K |
| Renaissance Technologies | 0.00% | Reduce -25.3% | 84,600 | $339K |
| Geode Capital Management, LLC | 0.00% | Add +5.6% | 82,907 | $333K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -7.8% | 59,000 | $237K |
| BlackRock Inc. | 0.00% | Reduce -10.1% | 30,864 | $124K |
| LPL Financial LLC | 0.00% | Add +133.3% | 28,000 | $112K |
| Two Sigma Advisers, LP | 0.00% | No change | 27,018 | $108K |
| State Street Corp. | 0.00% | Reduce -13.9% | 26,600 | $107K |
| Citadel Advisors | 0.00% | Reduce -31.8% | 25,948 | $104K |
| Boothbay Fund Management, LLC | 0.00% | Add +20.1% | 22,647 | $91K |
| Truist Financial Corp. | 0.00% | New | 20,000 | $80K |
| Two Sigma Investments, LP | 0.00% | Reduce -21.5% | 19,748 | $79K |
| Bank of New York Mellon Corp | 0.00% | No change | 17,907 | $72K |
| Simplex Trading, LLC | 0.00% | New | 17,850 | $71K |
| Northern Trust Corp. | 0.00% | Reduce -3.0% | 17,591 | $71K |
| Two Sigma Securities, LLC | 0.00% | New | 17,393 | $70K |
| Dimensional Fund Advisors LP | 0.00% | New | 12,126 | $49K |
| Susquehanna International Group, LLP | 0.00% | New | 11,185 | $45K |
| Oppenheimer & Co. Inc. | 0.00% | New | 10,000 | $40K |
| Acadian Asset Management LLC | 0.00% | No change | 6,314 | $25K |
| Royal Bank of Canada | 0.00% | Add +447.5% | 3,986 | $16K |
| UBS Group AG | 0.00% | Add +306.7% | 3,725 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -40.5% | 2,580 | $10K |
| ADAR1 Capital Management, LLC | 0.00% | Reduce -8.8% | 2,000 | $8K |
| Wells Fargo & Company | 0.00% | Add +0.2% | 570 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $401 |
| JPMorgan Chase & Co. | 0.00% | Add +37.5% | 22 | $88 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $8 |
"% of holder's portfolio" is TARA's weight in each manager's 13F, not the share of Protara Therapeutic Inc. the manager owns.